Sonoma Pharmaceuticals Inc Sustainability Reports
Sonoma Pharmaceuticals, Inc. is a global healthcare leader that develops and produces stabilized hypochlorous acid (HOCl) products for dermatological conditions, advanced tissue care, wound care, and animal health.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930008C5Z4F02SWO71
FIGI: BBG001SQ8K88
1 reports from 2026 to 2026